Granulomatous mastitis: from etiology and diagnosis to contemporary management—a narrative review
Gland Surgery · 2026-01 · ---
DOI: 10.21037/gs-2026-0498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gland Surgery, 2026-01. Verfasst von Puttiporn Naowaset.
Abstract (Originalsprache)
Background and Objective: Granulomatous mastitis (GM) is an uncommon, benign, chronic inflammatory disorder of the breast that frequently mimics breast carcinoma and breast abscess. Idiopathic GM (IGM), the diagnosis reached once specific secondary causes have been excluded, accounts for most cases, and cystic neutrophilic GM (CNGM) is a histopathological pattern strongly associated with Corynebacterium species. No universally accepted diagnostic or treatment algorithm exists. This narrative review aims to synthesize current evidence on the epidemiology, etiopathogenesis, diagnosis, and treatment of GM, with an emphasis on a practical, stepwise clinical approach.
Methods
PubMed, Scopus, and Embase were searched for English-language articles published between January 1, 2016 and August 5, 2026 using terms related to GM, IGM, diagnosis, and treatment. Of 533 records identified, 501 were assessed for relevance and 33 were selected purposively; 13 further publications were added separately, giving 46 publications that were synthesized narratively.Key Content and Findings: The pathogenesis of IGM is regarded as multifactorial: immune dysregulation, milk stasis, hyperprolactinemia, and Corynebacterium colonization are proposed contributing factors supported largely by observational evidence, and no causal agent has been established. Diagnosis rests on clinical assessment, breast imaging, and core needle biopsy with special stains and microbiological culture. Histological CNGM should be distinguished from microbiologically confirmed Corynebacterium infection, and a benign biopsy result should be accepted only when it is concordant with the imaging findings. Management options include observation, antibiotics, topical, intralesional, and systemic corticosteroids, steroid-sparing immunosuppressants, and surgery. The comparative evidence is predominantly observational and subject to confounding by indication, and no treatment has been shown to be superior. Reported recurrence rates range from 5% to 78%; several factors have been associated with recurrence, but none is an established independent predictor.
Conclusions
Management of GM should be individualized and stepwise, guided by disease severity, the presence of abscess or fistula, and evidence of infection, with malignancy excluded at every stage. Standardized severity classification and outcome definitions, and multicenter randomized trials, are needed to define optimal treatment.
Zitieren
APA
Naowaset, P. (2026). Granulomatous mastitis: from etiology and diagnosis to contemporary management—a narrative review. Gland Surgery, 0(0), ---. https://doi.org/10.21037/gs-2026-0498
Vancouver
Naowaset P. Granulomatous mastitis: from etiology and diagnosis to contemporary management—a narrative review. Gland Surgery. 2026;0(0):---. doi:10.21037/gs-2026-0498
BibTeX
@article{Naowaset2026,
author = {Naowaset, Puttiporn},
title = {Granulomatous mastitis: from etiology and diagnosis to contemporary management—a narrative review},
journal = {Gland Surgery},
year = {2026},
volume = {0},
number = {0},
pages = {------},
doi = {10.21037/gs-2026-0498}
}
EUVIMED